SIGA - SIGA Technologies, Inc.
| Previous Close | 4.19 |
| Open | 4.20 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 4.20 - 4.49 |
| 52 Week Range | 1.90 - 4.49 |
| Volume | 46,164 |
| Avg. Volume | 47,603 |
| Market Cap | 346.41M |
| Beta | 1.48 |
| PE Ratio (TTM) | -8.52 |
| EPS (TTM) | -0.51 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.00 |
- GlobeNewswire•last month
SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017
NEW YORK, Sept. 20, 2017-- SIGA Technologies, Inc., a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that Dr. ...
Capital Cube•2 months agoSIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)
Capital Cube•4 months agoSIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)
Capital Cube•7 months agoSIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)
Capital Cube•7 months agoSIGA Technologies, Inc. :SIGA-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)
- TheStreet.com•11 months ago
PharmAthene Declares Special Cash Dividend
The biodefense company on Thursday declared a special one-time cash dividend, a day after receiving final payment from Siga in connection with a drug license dispute.
- Business Wire•11 months ago
SIGA Announces Successful Completion of Rights Offering; Funding of Loan; Completion of Payment of PharmAthene Obligation
SIGA Technologies, Inc. today announced the successful completion of its previously announced rights offering , pursuant to which it raised approximately $35.3 million through the sale of 23,523,195 shares of its common stock.
Capital Cube•11 months agoSIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016
Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Sarepta Therapeutics, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (SRPT-US, BCRX-US and NLNK-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)